SAFETY AND EFFICACY OF EXISULIND FOR TREATMENT OF RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMYErik T. Goluboff, Carl A. Olsson, MARTIN MADORSKY et al.|The Journal of Urology|2001Cited by 77
288eTiP A multicenter, open-label, first-in-human study of TYRA-430 in advanced hepatocellular carcinoma and other solid tumors with activating FGF/FGFR pathway aberrations (SURF431)Love Goyal, A. Zalutskaya, Raed Moh’d Taiseer Al-Rajabi et al.|Annals of Oncology|2025Cited by 0